background. Dermatologic surgeons frequently see patients with body dysmorphic disorder, a distressing or impairing preoccupation with a nonexistent or slight defect in appearance. Recognition of this disorder is essential to avoid unnecessary and generally unsatisfying surgical outcomes, but no screening tools are available for use in a dermatology setting. objective. To develop and validate a brief self-report questionnaire to screen for body dysmorphic disorder in dermatology settings. methods. A questionnaire was developed and its sensitivity and specificity determined in 46 subjects, using a reliable clini- also determined ( n ϭ 50) . results. The self-report questionnaire had a sensitivity of 100% and a specificity of 93%. The interrater reliability (ICC) of the defect rating scale was .88. conclusions. This brief questionnaire was a highly effective screening tool for body dysmorphic disorder in a cosmetic dermatology setting. Use of this questionnaire may help identify patients with this syndrome.
BODY DYSMORPHIC DISORDER is a psychiatric condition that consists of a distressing and/or impairing preoccupation with a nonexistent or slight defect in appearance. 1 In the dermatology literature, patients with body dysmorphic disorder have been described as having dysmorphic syndrome, 2,3 dermatologic hypochondriasis, 4 dermatologic nondisease, 5 or a variant of monosymptomatic hypochondriasis. 6 Patients with body dysmorphic disorder are distressed by their perceived defect and frequently withdraw from family, work, and social activities. [7] [8] [9] The distress may be associated with depression and may even lead to suicide. 5, [7] [8] [9] [10] [11] Dermatologists frequently see these patients, who usually present with complaints of skin defects. 8, 12, 13 In an attempt to fix the perceived appearance flaw, patients may see numerous physicians, usually with a poor treatment outcome. 2 The literature suggests that patients with body dysmorphic disorder are also often dissatisfied with surgical treatment and may sue, threaten, or even become violent toward the treating physician. 9, 11, 13, 14 While an experienced surgeon may not proceed with surgery due to detection of body dys-morphic disorder symptoms and inappropriate treatment requests, the disorder often goes unrecognized and thus may not be appropriately addressed. 3, 5, 15 This can be problematic, as recognition of the syndrome is imperative not only to avoid unnecessary and dissatisfying surgical procedures, but also to initiate more appropriate and potentially successful psychiatric treatment.
A brief screening questionnaire for body dysmorphic disorder (the Body Dysmorphic Disorder Questionnaire) has been developed for use in psychiatric settings. 16 This questionnaire is based on the standard definition of body dysmorphic disorder as described in DSM-IV (1), which consists of the following three criteria: 1) the patient is preoccupied with an imagined defect in appearance; if a slight physical anomaly is present the concern is markedly excessive; 2) the concern causes clinically significant distress or impairment in functioning; and 3) the appearance preoccupation is not better accounted for by another mental disorder (such as anorexia nervosa). The Body Dysmorphic Disorder Questionnaire has been demonstrated to have good sensitivity (100%) and specificity (89%) in a psychiatric setting; 16 however, its psychometric properties have not been established in a dermatology setting. We therefore investigated the sensitivity and specificity of this screening tool in the cosmetic portion of a dermatologic surgery practice. To our knowledge, this is the first tool to screen for body dysmorphic disorder in a dermatology setting.
Method
The Body Dysmorphic Disorder Questionnaire developed for a psychiatric setting was slightly modified; this modification consisted of substituting a Likert scale from 1 to 5 indicating a range of severity for "yes/no" responses (Body Dysmorphic Disorder Questionnaire-Dermatology Version (Appendix 1)).
This study was conducted in an outpatient cosmetic and laser surgery clinic at a university hospital. Patients presenting for a cosmetic surgical consultation completed this selfreport questionnaire prior to the consultation. Patients seeking treatment for other types of dermatologic problems were excluded. If the patient acknowledged on the Body Dysmorphic Disorder Questionnaire that they were preoccupied with their appearance, they then answered two further questions, rating the severity of their distress or impairment in functioning due to the perceived appearance flaw on a scale of 1 to 5. If the perceived defect caused the patient to avoid things, they completed several yes/no questions that inquired about interference in academic, occupational, social, or other pursuits.
Using a brief, previously published 9,16 clinician-administered reliable semistructured instrument based on DSM-IV criteria for body dysmorphic disorder (Body Dysmorphic Disorder Diagnostic Module; Appendix 2), the dermatologic surgeon independently evaluated each patient, without knowledge of the patient's questionnaire results, for the presence of body dysmorphic disorder as part of the consultative process. This interview was considered the gold standard for the diagnosis of body dysmorphic disorder.
The study and the questionnaire were approved by an institutional review board. Informed consent was obtained from each patient. After obtaining informed consent, 46 patients and questionnaires were evaluated.
The interrater reliability of a defect severity scale was also determined because the physical defect must be nonexistent or only slight to meet the criteria for body dysmorphic disorder. The scale ranges from 1 to 5, 1 ϭ no defect, 2 ϭ minimal/slight defect, 3 ϭ defect present/clearly noticeable at conversational distance, 4 ϭ moderately severe defect, and 5 ϭ severe defect, (see Appendix 2) . The four authors rated 50 Kodachrome clinical slides of a variety of dermatologic lesions of varying severity. Interrater reliability was determined by calculating the intraclass correlation (ICC).
Results
Of the 46 patients who participated in the study, 36 (78.3%) were female and 10 (21.7%) were male. The mean age was 42.0 Ϯ 13.0 years (range 14-74 years). The most common dermatologic diagnosis was telangiectasia ( n ϭ 11; 23.9%).
Of the 46 patients who were evaluated by the dermatologist with the Body Dysmorphic Disorder Diagnostic Module and the Defect rating scale, 7 (15.2%) patients had current body dysmorphic disorder. On the self-report screening questionnaire (Body Dysmor-phic Disorder Questionnaire-Dermatology Version), using the presence of preoccupation as well as at least moderate distress or impairment in functioning to indicate the presence of body dysmorphic disorder, 9 (19.6%) subjects screened positive for body dysmorphic disorder. In three cases the questionnaire suggested that body dysmorphic disorder was present, but the diagnosis was not substantiated by the interviewer. This resulted in a sensitivity for the questionnaire of 100% and a specificity of 92.3%. The positive predictive value was 70.0% and the negative predictive value was 100%.
The charts of the three patients who screened positive for body dysmorphic disorder on the Body Dysmorphic Disorder Questionnaire but who were not diagnosed with body dysmorphic disorder by the dermatologist at the initial interview were subsequently reviewed. One of these patients clearly demonstrated symptoms of body dysmorphic disorder in the postoperative period, although body dysmorphic disorder had not been apparent at the time of consultation. Thus the questionnaire's specificity was even higher than in the initial analysis (94.7%). The interrater reliability of the defect rating scale was .88 (ICC).
Discussion
This study found that a simple screening questionnaire, in combination with an assessment of the severity of the perceived defect, had a high sensitivity and specificity for the diagnosis of body dysmorphic disorder in a dermatologic surgery cosmetic practice. As with any screening tool, it is better to overdiagnose than to underdiagnose an illness; brief follow-up questioning by the dermatologist, using questions such as those provided in Appendix 2, can be used to confirm the diagnosis suggested by the self-report questionnaire.
A fairly high percentage of the patients completing the questionnaire had body dysmorphic disorder (15%), and in a subsequent larger study ( n ϭ 268) in both a cosmetic dermatology setting (the same setting as the present study) and a general community practice, nearly as many patients (12%) screened positive for body dysmorphic disorder (12) . It is possible that the actual rate of body dysmorphic disorder in cosmetic dermatology populations is even higher than this, although further studies are needed to investigate this question. Other studies have reported the rate of body dysmorphic disorder in cosmetic surgery practices to be in a similar range of 6-15%. [17] [18] [19] Rates of body dysmorphic disorder reported in the general population range from 0.7% to 2.2%, [20] [21] [22] indicating that it is not a rare disorder. Thus dermatologists and surgeons frequently encounter these often difficult to treat patients.
Treating patients with body dysmorphic disorder can be frustrating until the underlying problem is identified. Patients with body dysmorphic disorder have frequently seen a number of physicians for their perceived defect and are often dissatisfied with prior treatment. 8 They may ask for inappropriate and, at times, overly aggressive treatment for their perceived defects. They are frequently seen as difficult or demanding, especially in light of their minimal or even nonexistent defect. 7, 11, 15 In our clinical experience, reassuring these patients that they look fine or that dermatologic treatment is unnecessary is often ineffective. A suggestion of psychiatric care may be met with resistance. Refusal to treat the patient or referring them to another cosmetic physician does not address the patient's problem. Palliative, minimal approaches may be ineffective for the same reason. 23 Although the outcome of surgical treatment of body dysmorphic disorder has not been adequately studied, most patients presenting to a psychiatrist report that previous surgical or dermatologic treatment was ineffective or even worsened their appearance. 8, 13 Clinical impressions reported in the dermatology and surgery literature also indicate that the outcome with dermatologic treatment or surgery is often poor, with complications including dissatisfaction, litigation, violence toward the surgeon, depression, and suicide. 7, 14, [24] [25] [26] Often, even if surgery or dermatologic treatment successfully addresses the minor appearance flaw, the patient may then focus on a new perceived defect, which can lead to polysurgery. 7, 27 Because of the potential for multiple psychiatric complications with surgery, this approach appears to be unwise.
However, once body dysmorphic disorder is correctly diagnosed, these patients can usually be successfully treated using psychiatric approaches. 28 The dermatologist or cosmetic surgeon can approach the patient by first providing education about the diagnosis, explaining that they appear to have a known and treatable body image problem known as body dysmorphic disorder. 23 Educational materials on body dysmorphic disorder can be recommended. 9 The dermatologist or surgeon can then explain that dermatologic treatment or surgery usually appear to be unsuccessful for body dysmorphic disorder but that several treatments are often effective. These are serotoninreuptake inhibitors (eg, fluvoxamine, fluoxetine, citalopram, sertraline, or paroxetine) and cognitive-behavioral therapy. 28, 29 The patient can then be referred to a psychiatrist or other qualified mental health professional familiar with body dysmorphic disorder. For patients who refuse psychiatric referral and who the dermatologist or surgeon feels comfortable treating (eg, patients who are not suicidal), the surgeon or dermatologist could prescribe a serotonin-reuptake inhibi-tor, following current recommendations for an adequate treatment trial. 23, 29 This study has several limitations. One limitation is that the number of patients assessed was relatively small; another is that patients were seen in only one cosmetic surgery practice. The Body Dysmorphic Disorder Questionnaire's psychometric properties require confirmation in larger and more diverse dermatologic samples. In the meantime, our results suggest that the Body Dysmorphic Disorder Questionnaire is a useful screening tool in a cosmetic dermatology setting. Considering the severe morbidity that body dysmorphic disorder often causes, the apparent poor response to dermatologic and surgical treatment, and the encouraging results for psychiatric treatment, it is important for dermatologic surgeons to recognize this disorder and facilitate appropriate treatment.
